A

Affini-T Therapeutics

81 employees

Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2021

Funding rounds raised

Total raised

$175M

from 8 investors over 8 rounds

A

Affini-T Therapeutics raised $175M on March 22, 2022

Investors: Parker Institute for Cancer Immunotherapy, Humboldt Fund, Vida Ventures, LLC, Leaps by Bayer, fred hutch, Agent Capital, Catalio Capital Management and -

FAQ